SLT technology

Laser trabeculoplasty suitable for all open-angle glaucoma patientsProstaglandin-based topical therapy has been the ‘go-to treatment’ for open-angle glaucoma for decades. In contrast, laser trabeculoplasty has conventionally remained reserved for patients unresponsive or unable to adhere to medication-based therapy.
Better alternatives to standalone prostaglandin analog therapyPhysicians have the option of various adjunctive therapy when prostaglandin analog therapy alone is not sufficiently potent to lower IOP, i.e., they can add one agent, a fixed-combination therapy, or perform selective laser trabeculoplasty (SLT).
Quantel’s Optimus Fusion receives FDA 501(k) clearanceThe U.S. Food and Drug Administration (FDA) has granted 501(k) clearance to Quantel Medical’s Optimus Fusion integrated laser platform.
Market adoption of MIGS growingExperts discuss the growing market of MIGS, as well as their benefits and possible concerns, while examining alternative non-invasive intervention methods.